

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.38876258 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.29677119 |
| 3 | respiratory burst (GO:0045730) | 5.05586698 |
| 4 | cytidine deamination (GO:0009972) | 4.92015652 |
| 5 | cytidine metabolic process (GO:0046087) | 4.92015652 |
| 6 | cytidine catabolic process (GO:0006216) | 4.92015652 |
| 7 | sequestering of actin monomers (GO:0042989) | 4.83474055 |
| 8 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.34313947 |
| 9 | leukocyte aggregation (GO:0070486) | 4.27639007 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.13567896 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.12669002 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98975465 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91819554 |
| 14 | mast cell activation (GO:0045576) | 3.87370799 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85075424 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.79822608 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.79822608 |
| 18 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.72882846 |
| 19 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.68687965 |
| 20 | neutrophil activation (GO:0042119) | 3.65691787 |
| 21 | ribosomal small subunit assembly (GO:0000028) | 3.62766340 |
| 22 | granulocyte activation (GO:0036230) | 3.62044919 |
| 23 | response to peptidoglycan (GO:0032494) | 3.59669342 |
| 24 | viral transcription (GO:0019083) | 3.55669222 |
| 25 | cellular response to interferon-beta (GO:0035458) | 3.42828666 |
| 26 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.40954630 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40327277 |
| 28 | T cell migration (GO:0072678) | 3.39561798 |
| 29 | translational termination (GO:0006415) | 3.37999281 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 3.35340623 |
| 31 | defense response to protozoan (GO:0042832) | 3.32687703 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 3.32195193 |
| 33 | negative regulation of T cell apoptotic process (GO:0070233) | 3.32109309 |
| 34 | cellular response to zinc ion (GO:0071294) | 3.30558124 |
| 35 | ribosomal small subunit biogenesis (GO:0042274) | 3.27820412 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.26714957 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.26491475 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.26491475 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.26491475 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.26491475 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.26491475 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 3.26491475 |
| 43 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.23982169 |
| 44 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.23982169 |
| 45 | B cell mediated immunity (GO:0019724) | 3.21920110 |
| 46 | regulation of regulatory T cell differentiation (GO:0045589) | 3.21480312 |
| 47 | actin nucleation (GO:0045010) | 3.21008453 |
| 48 | negative T cell selection (GO:0043383) | 3.20427285 |
| 49 | response to interferon-beta (GO:0035456) | 3.20192367 |
| 50 | myeloid dendritic cell activation (GO:0001773) | 3.19566938 |
| 51 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.18213464 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.17182487 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15701118 |
| 54 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.12971856 |
| 55 | response to protozoan (GO:0001562) | 3.12153205 |
| 56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.12094430 |
| 57 | leukocyte degranulation (GO:0043299) | 3.11479713 |
| 58 | positive regulation of macrophage differentiation (GO:0045651) | 3.11331695 |
| 59 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.11130925 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10704542 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09851304 |
| 62 | cotranslational protein targeting to membrane (GO:0006613) | 3.09843946 |
| 63 | positive thymic T cell selection (GO:0045059) | 3.09113363 |
| 64 | DNA deamination (GO:0045006) | 3.07595258 |
| 65 | protein targeting to ER (GO:0045047) | 3.06330844 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 3.06006179 |
| 67 | myeloid dendritic cell differentiation (GO:0043011) | 3.04428716 |
| 68 | cellular response to type I interferon (GO:0071357) | 3.02755755 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.02755755 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.02075360 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00142359 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00004321 |
| 73 | positive regulation of mast cell activation (GO:0033005) | 2.99337034 |
| 74 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98151021 |
| 75 | response to type I interferon (GO:0034340) | 2.97077797 |
| 76 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.96999506 |
| 77 | regulation of tolerance induction (GO:0002643) | 2.96271683 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94174943 |
| 79 | negative thymic T cell selection (GO:0045060) | 2.93811486 |
| 80 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.93294325 |
| 81 | protein localization to endoplasmic reticulum (GO:0070972) | 2.93233575 |
| 82 | cellular extravasation (GO:0045123) | 2.92120644 |
| 83 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.89896845 |
| 84 | regulation of interleukin-8 secretion (GO:2000482) | 2.89402886 |
| 85 | response to interleukin-15 (GO:0070672) | 2.88944324 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 2.88894692 |
| 87 | T cell costimulation (GO:0031295) | 2.87754372 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 2.86873059 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86090877 |
| 90 | lymphocyte costimulation (GO:0031294) | 2.84561791 |
| 91 | leukocyte mediated cytotoxicity (GO:0001909) | 2.84065125 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 2.83194975 |
| 93 | detection of bacterium (GO:0016045) | 2.82691857 |
| 94 | positive regulation of lamellipodium assembly (GO:0010592) | 2.81727974 |
| 95 | positive regulation of interferon-alpha production (GO:0032727) | 2.81610046 |
| 96 | protein neddylation (GO:0045116) | 2.81246333 |
| 97 | lipoxygenase pathway (GO:0019372) | 2.80166840 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79116506 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.79116506 |
| 100 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.78781728 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77982319 |
| 102 | negative regulation of phagocytosis (GO:0050765) | 2.77686163 |
| 103 | translational elongation (GO:0006414) | 2.77540469 |
| 104 | viral life cycle (GO:0019058) | 2.76494361 |
| 105 | positive regulation of lymphocyte migration (GO:2000403) | 2.76343609 |
| 106 | thrombin receptor signaling pathway (GO:0070493) | 2.76010283 |
| 107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75900781 |
| 108 | mast cell degranulation (GO:0043303) | 2.75848198 |
| 109 | mast cell activation involved in immune response (GO:0002279) | 2.75848198 |
| 110 | positive T cell selection (GO:0043368) | 2.75630790 |
| 111 | detection of other organism (GO:0098543) | 2.74771101 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74402370 |
| 113 | negative regulation of viral genome replication (GO:0045071) | 2.72492180 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.71302566 |
| 115 | positive regulation of mast cell degranulation (GO:0043306) | 2.70888351 |
| 116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70888351 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.70873842 |
| 118 | regulation of mast cell activation (GO:0033003) | 2.70771979 |
| 119 | cellular defense response (GO:0006968) | 2.70125445 |
| 120 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.70096352 |
| 121 | regulation of T cell apoptotic process (GO:0070232) | 2.69713299 |
| 122 | neutrophil mediated immunity (GO:0002446) | 2.69611274 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.68900717 |
| 124 | regulation of platelet aggregation (GO:0090330) | 2.68225012 |
| 125 | positive regulation of cell killing (GO:0031343) | 2.67792059 |
| 126 | eosinophil chemotaxis (GO:0048245) | 2.67669379 |
| 127 | regulation of mast cell degranulation (GO:0043304) | 2.67063189 |
| 128 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.66042519 |
| 129 | cellular protein complex disassembly (GO:0043624) | 2.65968357 |
| 130 | negative regulation of interleukin-17 production (GO:0032700) | 2.65455262 |
| 131 | cellular response to interleukin-15 (GO:0071350) | 2.65287000 |
| 132 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.65057649 |
| 133 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64548864 |
| 134 | myeloid leukocyte activation (GO:0002274) | 2.64313725 |
| 135 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64153135 |
| 136 | T cell receptor signaling pathway (GO:0050852) | 2.63957838 |
| 137 | dendritic cell chemotaxis (GO:0002407) | 2.63703350 |
| 138 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.63594031 |
| 139 | negative regulation of stress fiber assembly (GO:0051497) | 2.63515961 |
| 140 | autophagic vacuole fusion (GO:0000046) | 2.63353811 |
| 141 | superoxide anion generation (GO:0042554) | 2.62968494 |
| 142 | regulation of cell killing (GO:0031341) | 2.62793703 |
| 143 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.62241038 |
| 144 | membrane raft organization (GO:0031579) | 2.61445324 |
| 145 | phagosome maturation (GO:0090382) | 2.58367864 |
| 146 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57187446 |
| 147 | regulation of lymphocyte migration (GO:2000401) | 2.57139070 |
| 148 | lymphocyte chemotaxis (GO:0048247) | 2.56761363 |
| 149 | monocyte chemotaxis (GO:0002548) | 2.56326400 |
| 150 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.55725931 |
| 151 | regulation of protein heterodimerization activity (GO:0043497) | 2.55202090 |
| 152 | reactive oxygen species biosynthetic process (GO:1903409) | 2.52871095 |
| 153 | dendritic cell differentiation (GO:0097028) | 2.52724466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.49935168 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.42345968 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.10819691 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.21193252 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61613319 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61213475 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.40635480 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.36747863 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.07368203 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.96394460 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95997488 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89725693 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.78300723 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74054228 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66636895 |
| 16 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64341327 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.61371613 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54106588 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53147630 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.40518908 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36477809 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.33896106 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.26771334 |
| 24 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.22525140 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21192729 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.10291322 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00945910 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94318599 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.92123960 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89706066 |
| 31 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85267755 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82480313 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80535535 |
| 34 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80438518 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79451870 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.78693492 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77241558 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69649901 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67750718 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67604230 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66173511 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66084364 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64225658 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63823965 |
| 45 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.61781457 |
| 46 | * MYB_26560356_Chip-Seq_TH1_Human | 1.60212449 |
| 47 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57347731 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55431502 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54063509 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53038053 |
| 51 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52686678 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50675775 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50258690 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46562986 |
| 55 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46330887 |
| 56 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.45564983 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.44472857 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42781472 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42384868 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41512650 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38852331 |
| 62 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37807846 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37606542 |
| 64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36753056 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34380505 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31468813 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31399036 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.31128196 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30998681 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30861190 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30215029 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29336886 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29164750 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26930588 |
| 75 | * MAF_26560356_Chip-Seq_TH2_Human | 1.26014903 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24761964 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22909229 |
| 78 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21399292 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21096456 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19796550 |
| 81 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.19709279 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19192519 |
| 83 | MYC_22102868_ChIP-Seq_BL_Human | 1.18450741 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16702674 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15926000 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15745547 |
| 87 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15269851 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.15169572 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14681553 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14320516 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14102251 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13407234 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13316008 |
| 94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12985997 |
| 95 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12931784 |
| 96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12159973 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10092479 |
| 98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09916350 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09895141 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09043605 |
| 101 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08321644 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08256378 |
| 103 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08235339 |
| 104 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07149303 |
| 105 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05611081 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04543571 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03000820 |
| 108 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02328017 |
| 109 | P300_27268052_Chip-Seq_Bcells_Human | 0.99401363 |
| 110 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98965540 |
| 111 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97053732 |
| 112 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94694706 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94176429 |
| 114 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.93872495 |
| 115 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91974274 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91762026 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91046304 |
| 118 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90996155 |
| 119 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89278384 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88374223 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88204914 |
| 122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87014878 |
| 123 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86225160 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86050927 |
| 125 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85542972 |
| 126 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83889685 |
| 127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82590841 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82415922 |
| 129 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82235255 |
| 130 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81324260 |
| 131 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80783042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.85039284 |
| 2 | MP0009785_altered_susceptibility_to | 3.86193520 |
| 3 | MP0005671_abnormal_response_to | 3.70456335 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.60072732 |
| 5 | MP0003436_decreased_susceptibility_to | 3.49094402 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.32143257 |
| 7 | MP0005025_abnormal_response_to | 3.13316427 |
| 8 | MP0000685_abnormal_immune_system | 3.08315592 |
| 9 | MP0006082_CNS_inflammation | 2.97994825 |
| 10 | MP0002419_abnormal_innate_immunity | 2.97491669 |
| 11 | MP0001800_abnormal_humoral_immune | 2.85807794 |
| 12 | MP0001790_abnormal_immune_system | 2.85077506 |
| 13 | MP0005387_immune_system_phenotype | 2.85077506 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.78679574 |
| 15 | MP0002723_abnormal_immune_serum | 2.76246423 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.67770163 |
| 17 | MP0001819_abnormal_immune_cell | 2.67312123 |
| 18 | MP0003303_peritoneal_inflammation | 2.61563234 |
| 19 | MP0003724_increased_susceptibility_to | 2.56985535 |
| 20 | MP0002405_respiratory_system_inflammati | 2.21962622 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.21412811 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.20190826 |
| 23 | MP0002398_abnormal_bone_marrow | 2.10282323 |
| 24 | MP0001853_heart_inflammation | 2.09322218 |
| 25 | MP0004510_myositis | 2.08765710 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.08382388 |
| 27 | MP0000716_abnormal_immune_system | 2.06054357 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.05812000 |
| 29 | MP0002006_tumorigenesis | 2.00531777 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.87274256 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.79212587 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.72177060 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.70918501 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.69619440 |
| 35 | MP0002429_abnormal_blood_cell | 1.68544693 |
| 36 | MP0002722_abnormal_immune_system | 1.66918281 |
| 37 | MP0005310_abnormal_salivary_gland | 1.66596109 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.64157402 |
| 39 | MP0000343_altered_response_to | 1.61246092 |
| 40 | MP0004947_skin_inflammation | 1.61213226 |
| 41 | MP0000858_altered_metastatic_potential | 1.53034630 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.52474897 |
| 43 | MP0008004_abnormal_stomach_pH | 1.46264680 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.43883885 |
| 45 | MP0003448_altered_tumor_morphology | 1.43037210 |
| 46 | MP0008469_abnormal_protein_level | 1.39974236 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.37243966 |
| 48 | MP0003866_abnormal_defecation | 1.35535710 |
| 49 | MP0002933_joint_inflammation | 1.29266425 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.28873103 |
| 51 | MP0001851_eye_inflammation | 1.25039688 |
| 52 | MP0001873_stomach_inflammation | 1.24532446 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.24015786 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.22135247 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.18524589 |
| 56 | MP0006054_spinal_hemorrhage | 1.17760527 |
| 57 | MP0009764_decreased_sensitivity_to | 1.16646591 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.16348116 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.16348116 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.15884969 |
| 61 | MP0002735_abnormal_chemical_nociception | 1.13570070 |
| 62 | MP0005083_abnormal_biliary_tract | 1.13542924 |
| 63 | MP0000490_abnormal_crypts_of | 1.13173642 |
| 64 | MP0009840_abnormal_foam_cell | 1.09540453 |
| 65 | MP0003186_abnormal_redox_activity | 1.04454615 |
| 66 | MP0003279_aneurysm | 1.03339698 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.01925710 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.01571496 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.99703628 |
| 70 | MP0003075_altered_response_to | 0.99006489 |
| 71 | MP0000920_abnormal_myelination | 0.98117487 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.96403430 |
| 73 | MP0005166_decreased_susceptibility_to | 0.95522533 |
| 74 | MP0002736_abnormal_nociception_after | 0.94379584 |
| 75 | MP0003045_fibrosis | 0.94143425 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.90202186 |
| 77 | MP0003300_gastrointestinal_ulcer | 0.84046240 |
| 78 | MP0001663_abnormal_digestive_system | 0.82581072 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.82571722 |
| 80 | MP0000604_amyloidosis | 0.81252039 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.80378185 |
| 82 | MP0005023_abnormal_wound_healing | 0.79983376 |
| 83 | MP0005164_abnormal_response_to | 0.79486461 |
| 84 | MP0002163_abnormal_gland_morphology | 0.78926713 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.78772287 |
| 86 | MP0001968_abnormal_touch/_nociception | 0.78732884 |
| 87 | MP0001958_emphysema | 0.78095848 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.75172907 |
| 89 | MP0005390_skeleton_phenotype | 0.73722717 |
| 90 | MP0001905_abnormal_dopamine_level | 0.73413381 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.70880822 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.69809666 |
| 93 | MP0008874_decreased_physiological_sensi | 0.66702195 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.66679657 |
| 95 | MP0004883_abnormal_blood_vessel | 0.66195557 |
| 96 | MP0005409_darkened_coat_color | 0.65483698 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.65113582 |
| 98 | MP0009763_increased_sensitivity_to | 0.64929481 |
| 99 | MP0000249_abnormal_blood_vessel | 0.63071867 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.62769849 |
| 101 | MP0008873_increased_physiological_sensi | 0.62685591 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.61822019 |
| 103 | MP0001970_abnormal_pain_threshold | 0.61523890 |
| 104 | MP0009278_abnormal_bone_marrow | 0.60687156 |
| 105 | MP0004381_abnormal_hair_follicle | 0.60522812 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.60392621 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.60039270 |
| 108 | MP0003828_pulmonary_edema | 0.58301597 |
| 109 | MP0005410_abnormal_fertilization | 0.57897590 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.56178892 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.55489777 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.54288895 |
| 113 | MP0008260_abnormal_autophagy | 0.53556767 |
| 114 | MP0002132_abnormal_respiratory_system | 0.52367876 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.51396632 |
| 116 | MP0005165_increased_susceptibility_to | 0.50283350 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.49833658 |
| 118 | MP0001542_abnormal_bone_strength | 0.49433336 |
| 119 | MP0003795_abnormal_bone_structure | 0.48444685 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.43546079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.46492719 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.68515522 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.61163833 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.47244170 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.72693497 |
| 6 | Myositis (HP:0100614) | 4.50024295 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 4.36917121 |
| 8 | Obstructive lung disease (HP:0006536) | 4.36917121 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.25368362 |
| 10 | Stomatitis (HP:0010280) | 4.20102284 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.13218311 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.01212976 |
| 13 | Epistaxis (HP:0000421) | 3.96050108 |
| 14 | Recurrent skin infections (HP:0001581) | 3.87083158 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.71907404 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.70737278 |
| 17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.47149081 |
| 18 | Menorrhagia (HP:0000132) | 3.42006594 |
| 19 | Chronic otitis media (HP:0000389) | 3.38661180 |
| 20 | Orchitis (HP:0100796) | 3.37444355 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.36174711 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.36174711 |
| 23 | Meningitis (HP:0001287) | 3.33003083 |
| 24 | Gingival bleeding (HP:0000225) | 3.31784569 |
| 25 | Petechiae (HP:0000967) | 3.30188712 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.28705580 |
| 27 | Optic neuritis (HP:0100653) | 3.28705580 |
| 28 | Vasculitis (HP:0002633) | 3.27853882 |
| 29 | IgM deficiency (HP:0002850) | 3.27673159 |
| 30 | Abnormal platelet volume (HP:0011876) | 3.25009512 |
| 31 | Increased IgM level (HP:0003496) | 3.12000376 |
| 32 | Gingivitis (HP:0000230) | 3.11502768 |
| 33 | Recurrent bronchitis (HP:0002837) | 3.10968288 |
| 34 | Encephalitis (HP:0002383) | 3.10108489 |
| 35 | Aplastic anemia (HP:0001915) | 3.08876944 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.07714392 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.03063334 |
| 38 | Increased mean platelet volume (HP:0011877) | 2.94565944 |
| 39 | Recurrent viral infections (HP:0004429) | 2.94316428 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 2.89260565 |
| 41 | Cellulitis (HP:0100658) | 2.89251237 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.81095569 |
| 43 | Abnormal number of erythroid precursors (HP:0012131) | 2.78346174 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.74372500 |
| 45 | Thyroiditis (HP:0100646) | 2.72299715 |
| 46 | IgG deficiency (HP:0004315) | 2.71938544 |
| 47 | Impaired platelet aggregation (HP:0003540) | 2.70910345 |
| 48 | Abnormal platelet function (HP:0011869) | 2.70910345 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 2.70331766 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.70030157 |
| 51 | Thrombocytosis (HP:0001894) | 2.69176949 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.66648725 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.66635328 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 2.60470938 |
| 55 | Recurrent pneumonia (HP:0006532) | 2.60136450 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.56957626 |
| 57 | Abnormality of T cells (HP:0002843) | 2.56361722 |
| 58 | Chest pain (HP:0100749) | 2.54666772 |
| 59 | Leukocytosis (HP:0001974) | 2.54475754 |
| 60 | Exertional dyspnea (HP:0002875) | 2.52630198 |
| 61 | Hypoproteinemia (HP:0003075) | 2.52582420 |
| 62 | T lymphocytopenia (HP:0005403) | 2.51025590 |
| 63 | Urticaria (HP:0001025) | 2.50159634 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.47870501 |
| 65 | Lymphopenia (HP:0001888) | 2.45686217 |
| 66 | Episodic fever (HP:0001954) | 2.44979732 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44107430 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.43490581 |
| 69 | Increased serum ferritin (HP:0003281) | 2.43228946 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.41893819 |
| 71 | Joint swelling (HP:0001386) | 2.40646520 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.39023721 |
| 73 | Poor head control (HP:0002421) | 2.38882755 |
| 74 | Reticulocytopenia (HP:0001896) | 2.36984059 |
| 75 | Purpura (HP:0000979) | 2.36880929 |
| 76 | Pustule (HP:0200039) | 2.36127813 |
| 77 | Hemoptysis (HP:0002105) | 2.35673557 |
| 78 | Chronic diarrhea (HP:0002028) | 2.35546392 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33311209 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33311209 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33311209 |
| 82 | Panhypogammaglobulinemia (HP:0003139) | 2.33090337 |
| 83 | Sepsis (HP:0100806) | 2.32465957 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 2.31343422 |
| 85 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.30843937 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.30067175 |
| 87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26366304 |
| 88 | Gastrointestinal stroma tumor (HP:0100723) | 2.25836463 |
| 89 | Nasal polyposis (HP:0100582) | 2.24936865 |
| 90 | Pallor (HP:0000980) | 2.20653698 |
| 91 | Increased hepatocellular lipid droplets (HP:0006565) | 2.19765397 |
| 92 | Parakeratosis (HP:0001036) | 2.18148370 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 2.17666979 |
| 94 | Osteomyelitis (HP:0002754) | 2.17362483 |
| 95 | Axonal loss (HP:0003447) | 2.17272331 |
| 96 | Eosinophilia (HP:0001880) | 2.16137948 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.14991296 |
| 98 | Increased IgE level (HP:0003212) | 2.14064078 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.13249282 |
| 100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.13187347 |
| 101 | Systemic lupus erythematosus (HP:0002725) | 2.12792938 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07822245 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 2.06488830 |
| 104 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04389323 |
| 105 | Pulmonary fibrosis (HP:0002206) | 2.03728327 |
| 106 | Amyloidosis (HP:0011034) | 2.03520855 |
| 107 | Gangrene (HP:0100758) | 2.03514775 |
| 108 | Renal Fanconi syndrome (HP:0001994) | 2.02886903 |
| 109 | Dysostosis multiplex (HP:0000943) | 2.01253895 |
| 110 | Granulocytopenia (HP:0001913) | 2.01194191 |
| 111 | Chronic sinusitis (HP:0011109) | 2.00204725 |
| 112 | Mitochondrial inheritance (HP:0001427) | 1.99662457 |
| 113 | Glomerulopathy (HP:0100820) | 1.98578935 |
| 114 | Skin ulcer (HP:0200042) | 1.97005150 |
| 115 | Hypertensive crisis (HP:0100735) | 1.96274974 |
| 116 | Agnosia (HP:0010524) | 1.95749152 |
| 117 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.95524650 |
| 118 | Abnormality of the nasal mucosa (HP:0000433) | 1.95433167 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 1.95193670 |
| 120 | Arterial thrombosis (HP:0004420) | 1.94806704 |
| 121 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.94696842 |
| 122 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.94696842 |
| 123 | Anorexia (HP:0002039) | 1.94074933 |
| 124 | Acute hepatic failure (HP:0006554) | 1.93676478 |
| 125 | Abnormality of B cell number (HP:0010975) | 1.92220728 |
| 126 | B lymphocytopenia (HP:0010976) | 1.92220728 |
| 127 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91476339 |
| 128 | Erythema (HP:0010783) | 1.91268971 |
| 129 | Inflammation of the large intestine (HP:0002037) | 1.91129113 |
| 130 | Keratoconjunctivitis (HP:0001096) | 1.91117659 |
| 131 | Periodontitis (HP:0000704) | 1.90909310 |
| 132 | Pulmonary embolism (HP:0002204) | 1.89065858 |
| 133 | Skin rash (HP:0000988) | 1.88925201 |
| 134 | Abnormality of the pleura (HP:0002103) | 1.84999909 |
| 135 | Abnormality of the pericardium (HP:0001697) | 1.84667414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.62340414 |
| 2 | RIPK4 | 3.60759003 |
| 3 | NME2 | 3.47184802 |
| 4 | BLK | 3.42957811 |
| 5 | MAP3K12 | 3.37160473 |
| 6 | PIM2 | 2.95641814 |
| 7 | TXK | 2.75774602 |
| 8 | IRAK4 | 2.54744493 |
| 9 | KIT | 2.50080426 |
| 10 | TBK1 | 2.48338006 |
| 11 | TESK2 | 2.30054227 |
| 12 | MAP3K14 | 2.22931007 |
| 13 | EIF2AK3 | 2.04925480 |
| 14 | MST4 | 2.01486759 |
| 15 | TYK2 | 1.99177432 |
| 16 | SYK | 1.93949170 |
| 17 | ZAP70 | 1.88815830 |
| 18 | IKBKE | 1.86476926 |
| 19 | TEC | 1.85198921 |
| 20 | KDR | 1.77674302 |
| 21 | BCKDK | 1.75313765 |
| 22 | PBK | 1.70000731 |
| 23 | BTK | 1.67792476 |
| 24 | EIF2AK1 | 1.64820125 |
| 25 | VRK2 | 1.63868086 |
| 26 | JAK3 | 1.63684764 |
| 27 | ARAF | 1.63507384 |
| 28 | IKBKB | 1.53514683 |
| 29 | TESK1 | 1.48509043 |
| 30 | FES | 1.41975839 |
| 31 | MAP3K3 | 1.40400127 |
| 32 | CSF1R | 1.39403624 |
| 33 | LCK | 1.32884626 |
| 34 | TGFBR2 | 1.31487854 |
| 35 | LYN | 1.29085096 |
| 36 | LIMK1 | 1.27403834 |
| 37 | BUB1 | 1.23644987 |
| 38 | ADRBK2 | 1.22391426 |
| 39 | TAOK2 | 1.19177941 |
| 40 | GRK6 | 1.17516890 |
| 41 | STK16 | 1.16991825 |
| 42 | PIK3CG | 1.14324795 |
| 43 | HCK | 1.11007277 |
| 44 | ERN1 | 1.07104196 |
| 45 | SIK3 | 1.05901487 |
| 46 | LRRK2 | 1.04135444 |
| 47 | ABL2 | 1.03852015 |
| 48 | ITK | 1.03745416 |
| 49 | IRAK3 | 1.03581886 |
| 50 | MAP3K13 | 1.00186048 |
| 51 | MAP3K11 | 0.99986202 |
| 52 | GRK7 | 0.99801415 |
| 53 | CLK1 | 0.98041209 |
| 54 | PTK2B | 0.97979387 |
| 55 | BMX | 0.96476101 |
| 56 | GRK5 | 0.92851110 |
| 57 | MATK | 0.91905960 |
| 58 | JAK1 | 0.87565184 |
| 59 | PIM1 | 0.86819688 |
| 60 | BMPR2 | 0.86169545 |
| 61 | CDK19 | 0.84744899 |
| 62 | NEK9 | 0.82309624 |
| 63 | CSK | 0.81842970 |
| 64 | STK10 | 0.79562782 |
| 65 | MYLK | 0.76215814 |
| 66 | ILK | 0.73571060 |
| 67 | VRK1 | 0.72536180 |
| 68 | MAP2K3 | 0.72480689 |
| 69 | PRKCD | 0.68543493 |
| 70 | BMPR1B | 0.67650540 |
| 71 | MUSK | 0.67256652 |
| 72 | FGR | 0.64464423 |
| 73 | MAPKAPK5 | 0.63535002 |
| 74 | PRKCQ | 0.62556075 |
| 75 | ADRBK1 | 0.61555596 |
| 76 | SCYL2 | 0.60695828 |
| 77 | TLK1 | 0.59588804 |
| 78 | LMTK2 | 0.59162972 |
| 79 | PAK4 | 0.58262135 |
| 80 | DAPK1 | 0.58002582 |
| 81 | TAOK1 | 0.57973050 |
| 82 | DAPK3 | 0.57173135 |
| 83 | EPHB1 | 0.51404628 |
| 84 | MAP3K5 | 0.51314254 |
| 85 | TRPM7 | 0.50694315 |
| 86 | RAF1 | 0.50595414 |
| 87 | ACVR1B | 0.48794965 |
| 88 | TNK2 | 0.47096178 |
| 89 | EIF2AK2 | 0.46935792 |
| 90 | NLK | 0.46124424 |
| 91 | PDK1 | 0.43758268 |
| 92 | MARK3 | 0.43652091 |
| 93 | ABL1 | 0.42885570 |
| 94 | NME1 | 0.42303103 |
| 95 | FLT3 | 0.41315130 |
| 96 | TAOK3 | 0.41313522 |
| 97 | CAMKK2 | 0.40088139 |
| 98 | MOS | 0.39201271 |
| 99 | MAPKAPK2 | 0.39140468 |
| 100 | YES1 | 0.38950463 |
| 101 | MAPK4 | 0.38480948 |
| 102 | TNIK | 0.38279720 |
| 103 | ROCK1 | 0.36447033 |
| 104 | MAP3K1 | 0.36249139 |
| 105 | RPS6KA4 | 0.36101768 |
| 106 | JAK2 | 0.34960504 |
| 107 | MAPKAPK3 | 0.34812122 |
| 108 | PAK1 | 0.34740796 |
| 109 | IGF1R | 0.34404741 |
| 110 | PRKD1 | 0.34093353 |
| 111 | PRKD2 | 0.34006085 |
| 112 | RPS6KA6 | 0.33854461 |
| 113 | NUAK1 | 0.33387287 |
| 114 | FYN | 0.32922693 |
| 115 | MAP4K2 | 0.31708647 |
| 116 | CHUK | 0.31544934 |
| 117 | MAP2K6 | 0.30997558 |
| 118 | CDK8 | 0.29632503 |
| 119 | INSR | 0.29296967 |
| 120 | RPS6KB2 | 0.27230257 |
| 121 | PRKG2 | 0.26856942 |
| 122 | STK4 | 0.26780475 |
| 123 | SRC | 0.22283082 |
| 124 | PRKCA | 0.21257857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.20346646 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.76992010 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.57836012 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55734144 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54768333 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.42741354 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.42671012 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.17044424 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.11755485 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97974941 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92656680 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88129556 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82622462 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77262602 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76504845 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71919178 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.71098524 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.68387891 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.68198661 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64176330 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61745298 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.60896494 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60014034 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57376320 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.57278794 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.56559639 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.50939159 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.49937209 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47627053 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47183010 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.45008966 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.38788578 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.38669580 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.33849025 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.33002569 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32363601 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32307376 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28421359 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22801843 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.22432807 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 1.21487567 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18562465 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17379762 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14687945 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13410890 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10895609 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.09154129 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06857736 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04863145 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03928024 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03588953 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01099845 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00954963 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.00761878 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99015307 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98387209 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96462117 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93172971 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92185539 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.90903292 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.84741616 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84451759 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81874039 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.81867062 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81573615 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80405691 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80204224 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78695318 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77323063 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.75130936 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70468772 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70100656 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68881267 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68675047 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67078724 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66147784 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65526405 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.57688645 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53961933 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53908474 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52147781 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.52047434 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51060127 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47342278 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45875179 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.43140332 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41067778 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.40124778 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40038153 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39744759 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33912754 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33766407 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33220782 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32062317 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30780704 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30764901 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30532041 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30274840 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29957589 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29927829 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29793183 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29307378 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29303002 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.28602798 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28257106 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26580047 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26000121 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25151020 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24732795 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.20573499 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.20432253 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20056833 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18615138 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16931758 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11902024 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.10392542 |

